Fig. 2From: Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunctionYear 2 sample flowchart. Selection of COLT lung transplant recipients with CLAD or a stable phenotype. Other phenotypes included death before 3 months, death without CLAD and an inconclusive phenotype (insufficient data or cofounding factors affecting the adjudication). “No phenotypes” refer to recipients awaiting adjudication.* One recipient was initially classified as having azithromycin-responsive allograft dysfunction and was not included in the stable group for the year 1 sample analysis but later developed CLAD and was included in the CLAD group for the year 2 sample analysisBack to article page